We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,176

The Demise of Valeant Pharmaceuticals: A Case Study in Rotten Culture and Business Ethics
  • Volkov Law Group
  • USA
  • April 3 2016

Showing my age again, Woody Allen’s Take the Money and Run included a hilarious scene when Woody’s parents wearing Groucho Marx glasses talk about


eCommerce Regulation, Bitcoin, Anti-Money Laundering, Shadow Insurance, 401(k) Litigation Expect Focus - Vol. IV, Fall 2015
  • Carlton Fields
  • USA
  • December 23 2015

On January 1, 2016, Section 38.6 of the California Insurance Code will take effect permitting consumers to conduct certain life, disability, and


Corporate Crime & Investigations Update - 11 January 2016
  • Addleshaw Goddard LLP
  • Ukraine, United Kingdom, USA
  • January 11 2016

Southwark Crown Court ordered Smith and Ouzman Ltd. to pay a total of approximately £2.2 million in relation to bribes paid to public officials for


Advice of counsel defense in US v. Lauren Stevens: dismissal of indictment is not necessarily good news for companies
  • Hogan Lovells
  • USA
  • March 25 2011

The indictment last November of former GlaxoSmithKline (GSK) in-house counsel, Lauren Stevens, for purportedly obstructing a U.S. Food and Drug Administration (FDA) investigation into whether GSK marketed Wellbutrin, an anti-depressant drug, off-label, falsifying and concealing documents, and making false statements sent shockwaves through the legal community


The State AG Report Weekly Update January 7, 2016
  • Cozen O'Connor
  • USA
  • January 7 2016

Kansas AG Derek Schmidt reached a settlement with American Handicapped & Disadvantaged Workers, Inc., (“ADHW”) and its president and CEO for


Major cases only, please
  • Bracewell LLP
  • USA
  • July 7 2014

At the American Health Lawyers Association meeting last week, Department of Justice officials signaled that the Department may shift to a model of


Recent prison sentences demonstrate government intent to increase criminal prosecutions of liable corporate officials
  • Arnall Golden Gregory LLP
  • USA
  • December 5 2011

In late November, two former senior executives of Synthes Inc. were sentenced to nine months in prison and a third sentenced to five months in prison for their management roles in a company that marketed a medical device for an unauthorized use and conducted unauthorized clinical trials


State AGs in the news
  • Dickstein Shapiro LLP
  • USA
  • June 26 2014

Don Quick (D) and Cynthia Coffman (R) received their respective party's nomination after both ran unopposed in the primary. Incumbent AG John Suthers


Former GSK in-house counsel Lauren Stevens acquitted
  • Kelley Drye & Warren LLP
  • USA
  • May 10 2011

Earlier today, Honorable Roger W. Titus, who is the judge presiding over the Lauren Stevens trial, granted the defendant's motion for a judgment of acquittal, bringing the case to an end


Government puts in-house counsel in its cross-hairs
  • Venable LLP
  • USA
  • November 12 2010

Confirming recent statements by Department of Justice ("DOJ") and Food & Drug Administration ("FDA") officials that the government will increasingly target individual executives for criminal prosecution, DOJ has indicted a former Associate General Counsel for pharmaceutical giant GlaxoSmithKline ("GSK") on two counts of obstruction of justice and four counts of making false statements during an FDA investigation